T2-weighted MRI correlates with long-term histopathology, neurology scores, and skilled motor behavior in a rat stroke model

Annals of the New York Academy of Sciences

Volumn 939, Issue , 2001, Pages 283-296

  Palmer, Gene C ^a   Peeling, James ^b   Corbett, Dale ^c   Del Bigio, Marc R ^b   Hudzik, Thomas J ^a  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF MANITOBA   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Behavior; Histopathology; MRI; Stroke; Transient focal ischemia

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN INJURY; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; HISTOPATHOLOGY; LOCOMOTION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; STROKE; ANIMAL; ARTICLE; BRAIN; CEREBRAL ARTERY DISEASE; DISEASE MODEL; METHODOLOGY; MOTOR ACTIVITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE IMAGING; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0034743293     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03636.x     Document Type: Conference Paper

References (23)

1. [(S)-Alpha-phenyl-2-pyridine-ethanamine dihydrochloride], a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia
2. Efficacy of AR-R 15896AR in the rat monofilament model of transient middle cerebral artery occlusion
3. NPS 1506, a novel NMDA receptor antagonist and neuroprotectant
4. HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat
5. Paw-reaching, sensorimotor and rotational behavior after brain infarction in rats
6. Long-term functional end points following middle cerebral artery occlusion in the rat
7. Reversible middle cerebral artery occlusion without craniotomy in rats
8. The temporal evolution of MRI tissue signatures after transient middle cerebral artery occlusion in rat
9. Combined neuroprotection and repeffusion therapy for stroke. Effect of lubeluzole and diaspirin cross-linked hemoglobin in experimental focal ischemia
10. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats
11. Correlation of CGS 19755 neuroprotection against in vitro excitotoxicity and focal cerebral ischemia
12. Magnetic resonance imaging assessment of evolving focal cerebral ischemia: Comparison with histopathology in rats
13. Pitfalls and potential of clinical diffusion-weighted MR imaging in acute stroke
14. Reduction of excitotoxicity-induced brain damage by the competitive NMDA antagonist CGP 40116: A longitudinal study using diffusion-weighted imaging
15. Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI
16. AR-R 15896AR reduces cerebral infarct volume following focal ischemia in cat
17. Continuing postischemic neuronal death in CA1. Influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats
18. Delayed postischemic hypothermia: A six month survival study using behavioral and histological assessments of neuroprotection
19. Functional benefit from clomethiazole treatment after focal cerebral ischemia in a nonhuman primate species
20. Pharmacological effects of remacemide and MK-801 on memory and hippocampal CA1 damage in the rat four-vessel occlusion (4-VO) model of global ischemia
21. Measurement of infarct size using MRI predicts prognosis in middle cerebral artery infarction
22. Relating MRI changes to motor deficit after ischemic stroke by segmentation of functional motor pathways
23. Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanism of damage and treatment